Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) Cash from Operations (2022 - 2026)

Genelux (GNLX) posted Cash from Operations of -$6.1 million for Q1 2026, up 1.61% on a QoQ basis from -$6.2 million in Q4 2025, and down 12.24% year-over-year from -$7.0 million in Q1 2025.

Analysis

Genelux (GNLX) Cash from Operations (2022 - 2026) Analysis & Trends

Genelux has reported Cash from Operations for 5 years, with the latest figure at -$6.1 million in Q1 2026.

  • On a quarterly basis, Cash from Operations fell 12.24% year-over-year to -$6.1 million in Q1 2026; TTM through Mar 2026 was -$26.0 million, a 16.39% decrease from a year earlier, with the FY2025 full-year figure at -$25.3 million, down 19.18% from the prior year.
  • Cash from Operations was -$6.1 million for Q1 2026 at Genelux, up from -$6.2 million in the prior quarter.
  • The five-year high for Cash from Operations was $2.8 million in Q1 2022, with the low at -$7.1 million in Q2 2025.
  • Average Cash from Operations over 5 years is -$4.8 million, with a median of -$5.4 million recorded in 2025.
  • The sharpest annual moves came in 2023 and 2024: Cash from Operations sank 355.2% in 2023, then soared 37.74% in 2024.
  • Over 5 years, Cash from Operations stood at -$1.5 million in 2022, then sank by 355.2% to -$6.9 million in 2023, then jumped by 37.74% to -$4.3 million in 2024, then slumped by 44.12% to -$6.2 million in 2025, then advanced by 1.61% to -$6.1 million in 2026.
  • The last three Cash from Operations figures came in at -$6.1 million (Q1 2026), -$6.2 million (Q4 2025), and -$6.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 4.00 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 3.57 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.13 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 813.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -526.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 326.72 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 448.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -270.50 Mn
10 Genelux 108.17 Mn 108.17 Mn - -6.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.10 Mn
Dec 31, 2025 -6.20 Mn
Sep 30, 2025 -6.60 Mn
Jun 30, 2025 -7.07 Mn
Mar 31, 2025 -5.44 Mn
Dec 31, 2024 -4.30 Mn
Sep 30, 2024 -5.75 Mn
Jun 30, 2024 -6.82 Mn
Mar 31, 2024 -4.35 Mn
Dec 31, 2023 -6.91 Mn
Sep 30, 2023 -3.36 Mn
Jun 30, 2023 -5.42 Mn
Mar 31, 2023 -4.59 Mn
Dec 31, 2022 -1.52 Mn
Mar 31, 2022 2.83 Mn